KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

ClearPoint Neuro (CLPT) EBT Margin (2018 - 2025)

Historic EBT Margin for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to 66.39%.

  • ClearPoint Neuro's EBT Margin fell 53200.0% to 66.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 68.02%, marking a year-over-year decrease of 82400.0%. This contributed to the annual value of 62.91% for FY2024, which is 308000.0% up from last year.
  • As of Q3 2025, ClearPoint Neuro's EBT Margin stood at 66.39%, which was down 53200.0% from 63.07% recorded in Q2 2025.
  • In the past 5 years, ClearPoint Neuro's EBT Margin ranged from a high of 54.08% in Q1 2024 and a low of 119.85% during Q2 2023
  • Its 5-year average for EBT Margin is 78.43%, with a median of 73.75% in 2022.
  • Its EBT Margin has fluctuated over the past 5 years, first crashed by -413100bps in 2021, then soared by 639400bps in 2024.
  • ClearPoint Neuro's EBT Margin (Quarter) stood at 92.99% in 2021, then rose by 7bps to 86.37% in 2022, then increased by 20bps to 69.1% in 2023, then fell by -5bps to 72.68% in 2024, then grew by 9bps to 66.39% in 2025.
  • Its EBT Margin was 66.39% in Q3 2025, compared to 63.07% in Q2 2025 and 70.81% in Q1 2025.